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1. Introduction 
Hepatocellular carcinoma is the third-leading cause of global cancer-related mortality. 
Major causes of this disease are hepatotropic viruses including hepatitis B and C viruses, 
nonalcoholic steatohepatitis, alcohol, autoimmunity, primary biliary cirrhosis, primary 
sclerosing cholangitis, vascular disorders and so on (Olsen et al., 2010). These factors 
related to hepatitis lead the patients to the high-risk group for decompensated liver 
cirrhosis and hepatocellular carcinoma during their clinical course in 20–30 years. 
Interferon or other medical therapy for each disease have been accommodating better 
conditions of the liver and make it possible to prolong their lives. However, the possibility 
of the occurrence of hepatocellular carcinoma could not have been completely avoided in 
these patients during their lifetime. 
Recently, the improvements of surveillance techniques and disease awareness have led to 
earlier diagnosis and more appropriate treatment for liver tumors. Surgical therapy could be 
curative treatment to avoid local recurrence, but many patients are unable to undergo 
surgical resection due to severely compromised liver function or multiple tumors. 
Moreover, frequent recurrence of heparocellular carcinoma makes it hazardous for the 
patients to undergo surgical therapy repeatedly to maintain the liver function after the 
treatment. Thus, non-surgical interventional therapy has been introduced to control 
hepatocellular carcinoma and have played an important role in the treatment of 
hepatocellular carcinoma (Livraghi et al, 1999; Poon et al, 2002). These locoregional therapies 
including transcatheter arterial chemoembolization, percutaneous ethanol injection therapy, 
percutaneous radiofrequeny ablation therapy and others, have been making significant 
contributions to reduce the decrease of the liver function and to maintain the condition of 
the patients (Poon et al, 2002; Buix et al, 2004; Orland et al, 2009). Radiofrequency ablation 
has provided one of the greatest recent advances in the treatment of hepatocellular 
carcinoma because of the improvement of the local control and the patient survival. 
Radiofrequency ablation is reported as a minimally invasive and effective treatment for 
small hepatocellular carcinoma and now this treatment is the most widely used technique of 
the therapy for hepatocellular carcinoma worldwide. Many studies have established the 
effectiveness of radiofrequency ablation in treating hepatocellular carcinoma (McGhana 
&Dodd, 2001; Livraghi et al, 2003; Lencioni et al, 2005; Tateishi et al, 2005; Choi et al, 2007) 
and have achieved to expand the indications for radiofrequency ablation. 
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However, one of the most characteristic complications of this therapy is that related to the 
thermal effect. We experienced a case that developed diaphragmatic hernia due to the 
thermal effect of radiofrequency ablation twenty months after the treatment for a tumor 
located in the segment VIII area of his liver. Patients who have undergone radiofrequency 
ablation for hepatic tumors adjacent to the diaphragm should be carefully followed up for 
possible damage of the diaphragm, even after the long postoperative intervals. Recently, the 
artificial ascites technique has been developed and introduced in this field. This technique 
could be approved for the prevention of the diaphragmatic damage and the thermal 
complications of the surrounding organs. 
2. Radiofrequency ablation for hepatocellular carcinoma 
Radiofrequency ablation includes the methods of tumor necrosis through the direct 
placement of the needles into the tumor under the ultrasonographical guide and the usage 
of alternating electrical current to create ionic agitation and frictional heating leading to the 
tissue damage. The benefits of this therapy include excellent local control comparable to 
surgical resection, low morbidity, repeatability for recurrence, preservation of liver function, 
and few complications (Livraghi et al, 1999; Poon et al, 2002).  
Although radiofrequency ablation is considered safe (Curley et al, 2000; Livraghi et al, 2000; 
Wood et al, 2000), some serious complications have been reported. These include bleeding 
from costal or hepatic artery, pneumothorax or puncture of surrounding organ, infection, 
pain, nausea or vomiting, and so on (Curley et al, 2000; Livraghi et al, 2000; Wood et al, 
2000). One of the most characteristic and unpredictable complications of this therapy is that 
induced by heat conduction. Even though the needle could be inserted into the appropriate 
lesion under the ultrasonographic guide, because the ablated area should be larger than the 
tumor and involving the whole tumor, it is difficult to grasp the ablated area around the 
tumor and the environmental situation precisely during the treatment. The ablation produce 
microbubbles due to heating up in the tissue surrounding the tumor resulting in occurrence 
of difficulty in grasping the precise ablated area. If the physicians could release the needle 
from the ultrasonographic transducer during the treatment, it could be possible to grasp 
roughly the area from other view points. However, high echoic area of microbubbles is not 
always identical to ablated area and sometimes expands beyond the thermal margin of the 
effective thermal area. Three-dimensional analysis with radiological study should be helpful 
to evaluate the ablated area, but it is impossible to predict before the treatment because of 
the existence of environmental factors of the ablated area including blood flow and 
respiratory movement of the liver.  
3. Technical difficulties for hepatocellular carcinoma situated at the dome of 
the liver 
Because all of the procedures for the liver diseases under ultrasonographic guidance need to 
be performed with the fully clear detection of the target site, insufficient and poor imaging 
of ultrasonography means the hardly successful treatment. However, ultrasonographic 
visualization of the whole tumor under the diaphragm is not always possible due to the 
atrophy of the right lobe of the cirrhotic liver and the normal respiratory expansion of the 
lung over the liver causing the acoustic shadow. Therefore, the deformity or the atrophy of 
the liver due to the chronic inflammation and the damage would make ultrasonographically 
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undetectable region in the liver and lead the physicians to have difficulties in such 
treatment. Hepatocellular carcinoma can locate in every lobe of the liver, and sometimes 
locates under the diaphragm dome and this could often be the key factor affecting the 
effectiveness or the insufficiency of this treatment (Koda et al, 2003; Kang et al, 2009). It may 
be unavoidable in such cases to make unintended burns to the diaphragm neighboring or 
close to the target tumor because physicians should burn larger area including 
hepatocellular carcinoma in order to gain the safety margin around it.  
4. Reported complications including a diaphragmatic hernia in the literature, 
and the case report 
4.1 A review of diaphragmatic hernia reported in the literature 
Mulier et al. reviewd the complication of radiofrequency ablation from 82 reports of 3670 
cases and reported that the prevalence of diaphragm burn was estimated as 0.1% (5 out of 
3670) (Mulier et al, 2002). However, Head HW et al. reported that 5 (17%) in 29 
radiofrequency ablation cases of hepatocellular carcinoma adjacent to the diaphragm had 
right shoulder pain and 3 cases showed thickening of the diaphragm induced by the thermal 
effect of radiofrequency ablation (Head et al, 2007). It is also reported that the symptom of 
diaphragm injury manifests as referred right shoulder pain that occurs during the treatment 
and can last up to 2 weeks after the ablation (Livraghi et al, 2003). It may be unavoidable in 
cases that hepatocellular carcinomas locate under the diaphragm dome to make unintended 
burn to the diaphragm because of the environmental and technical factors (Kang et al, 2009). 
The unintended burn of the limited area of the diaphragm may not induce any significant 
phenomena in the short term except in a few cases, but Curly et al. analyzed the data of 608 
cases and emphasized the risk of the late complications of the radiofrequency ablation 
treatment (Curley et al, 2004). It should be known that radiofrequency ablation could induce 
serious combined diseases more than several months after the treatment.  
4.2 Case report: Diaphragmatic hernia twenty months after percutaneous 
radiofrequency ablation for hepatocellular carcinoma 
In August, 2006, we experienced one case of a 50-year-old man with hepatitis B virus 
infection who underwent radiofrequency ablation for hepatocellular carcinoma of 2.2 cm in 
diameter located in the segment VIII area of his liver adjacent to the diaphragm (Figure 1a). 
The tumor could be almost fully scanned ultrasonographically and it was located just under 
the costal region close to the costpleural angle. Laboratory tests showed his liver function as 
Child-Pugh class A liver cirrhosis. 
Ultrasound-guided radiofrequency ablation was performed using RITA Medical System 
1500 RF generator attached to a 15-gauge Starburst XL model 90 probe needle for 20 minutes 
and the needle was expanded to 4cm in a stepwise manner. There was no technical problem 
and enough ablation area around hepatocellular carcinoma could be achieved with a safety 
margin of the necrotic area (Figure 1b). He did not feel nausea and did not complained 
about a thermal effect like right shoulder pain which could be a sign of diaphragm damage 
(Livraghi et al, 2003). After the procedure, he was discharged in a week without any adverse 
effects. He had been under observation in our hospital regularly and medicated by entecavir 
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to control hepatitis B virus replication. Since multiple recurrence lesions were detected in 
the segment VIII later, he was treated with transcatheter arterial chemoembolization therapy 
in April, 2007 and in February, 2008. 
 
Fig. 1. 50-year-old man with hepatocellular carcinoma. (adapted from Nawa T et al). 
a. Arterial phase computed tomography scan obtained prior to the radiofrequency 
ablation shows enhancing nodule (black arrows) in the segment VIII of the liver.  
b. Portal phase computed tomography scan obtained after the radiofrequency ablation 
shows the ablation zone (A). 
Twenty months later after the radiofrequency ablation treatment in April 2008, he was 
admitted to our hospital emergency department because of severe right hypochondralgia 
and dyspnea.  
 
 
Fig. 2. Computed tomography scan obtained at the hospital emergency department twenty 
months later after the radiofrequency ablation therapy. (adapted from Nawa T et al). 
a. Computed tomography scan shows the prolapsed large intestine and the omentum in 
his right pleural cavity (white arrows). 
b. Coronal multidetector computed tomography image of his chest shows the portion of 
the large intestine in the right lower thorax, indicating the anatomic relationship of the 
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Computed tomography revealed the prolapsed large intestine and the omentum through 
a defect on the right diaphragm (Figure 2a, 2b), and emergency surgery was performed to 
close the hole in the diaphragm following the diagnosis of diaphragmatic hernia. The 
operation showed that the ascending and transverse colon had been herniated into the 
right pleural cavity through the diaphragmatic hole which measured 5x3 cm in diameter 
(Figure 3) and no apparent invasion of hepatocellular carcinoma around the hole was 
observed. Although the colon was perforated in the pleural cavity and induced pyothorax 
after the operation, he recovered with the intense care using antibiotics and drainage 
(Nawa et al, 2010). 
 
Fig. 3. The photograph taken during the surgery. (adapted from Nawa T et al). 
This photograph is showing the hole in the diaphragm. 
In our case, the location of the diaphragm defect was apparently different from that of 
congenital diaphragmatic hernia and his clinical history showed that nothing other than the 
radiofrequency ablation could be the cause of the diaphragmatic perforation. The repeated 
treatments of transcatheter arterial chemoembolization against hepatocellular carcinoma 
recurrence during twenty months might accelerate the atrophy of the right lobe of his liver 
(Figure 4, a-d). This atrophic change could be thought to make the space between the liver 
and the diaphragm for his large intestine to access to the hole. 
It is often a problem of radiofrequency ablation using an expandable electrode that all of the 
multiple tips of the needle cannot always be detected under ultrasonography because the 
tips are multidirectional meaning there is a risk of puncture of vessels or other organs close 
to a tumor beyond the possible scan area. However, diaphragmatic hernia was reported not 
only in the case of expandable electrodes but also in the case of a single straight electrode. 
Therefore, the thermal effect for the diaphragm could not always be induced by the direct 
puncture of expandable electrode.  
Because this complication was observed in the cases of hepatocellular carcinoma located in 
the segment IV, VII or VIII close to the diaphragm, it should be recommended to follow 
carefully such cases, especially with the apparent atrophic change of the right lobe of the 
liver, as the high-risk groups of diaphragmatic hernia.  
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Fig. 4. Computed tomography scan obtained after the radiofrequency ablation therapy. 
(adapted from Nawa T et al). 
Computed tomography obtained in August, 2006, (a); in November, 2006,(b); in March, 
2007, (c); in May, 2007, (d). The serial computed tomography scans are showing the gradual 
atrophic change of the liver causing to space between the diaphragm and the liver. 
5. Technical solution for radiofrequency ablation for hepatocellular 
carcinoma at the dome of the diaphragm: The techniques of artificial ascites 
5.1 The purpose of the artificial ascites technique 
Radiofrequency ablation is difficult to perform if a tumor is located under the diaphragm 
because this region is often invisible or is poorly visible on ultrasonography. Local ablation 
therapy under laparoscopy or thoracoscopy could be a possible treatment in such case, but it 
is more invasive than percutaneous procedure and other special equipment would be 
needed. The artificial pleural or peritoneal effusion has been explored as a beneficial 
treatment option that offers excellent local control through visualization of hepatocellular 
carcinoma under the diaphragm (Katayama et al, 2002; Uehara et al, 2007; Rhim et al, 2008). 
It was meaningful that this method has been reported to be effective to keep enough space 
between the liver and the adjacent organs including the diaphragm by a solution that can 
cool down the local ablated area by circulating in the peritoneal space. The procedure of 
artificial ascites technique is briefly shown below.  
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5.2 Procedure of artificial ascites 
1. The location of the puncture site should be defined first as a clearly visible point in the 
liver with ultrasonography usually at the sixth to eighth intercostal space along the 
anterior to middle axillary line. It is necessary to avoid around the radiofrequency 
ablation puncture site for the artificial ascites puncture site since radiofrequency 
ablation treatment should be started during the artificial ascites procedure before the 
ascites spreads to other or lower abdominal cavity. If it is difficult to avoid the ablation 
puncture site for the artificial ascites puncture site, it is able to start making the artificial 
ascites at that site and try other sites after gaining a solution space in the abdominal 
cavity since there should be more puncture sites to make the ascites after gaining it.  
2. After the administration of the local anesthesia at the skin of the puncture site, an 18-
gauge sheathed needle would be prepared to insert into the peritoneal space. If the 
outer sheath has a side hole for infusion, it would be much easier and faster to achieve 
enough volume of ascites. The pneumoperitoneum needle can be used for the puncture 
of the appropriate site instead of the sheathed needle for this procedure.  
3. Patients are asked to perform inspiration to move the liver downward and then to hold 
the breath for a while. Oxygen administration could be helpful for the patients to hold 
the breath. The physician inserts the 18-gauge sheathed needle into the parenchyma of 
the liver (Figure 5a) and removes the inner stylet of the sheathed needle (Figure 5b).  
4. Next, the patients are asked to perform full expiration so that the needle sheath can slip 
away from the hepatic capsule and located in the perihepatic intraperitoneal space 
(Figure 5c). If the needle sheath could not slip away from the liver, further deep 
inspiration and expiration could help a successful placement of the sheath.  
5. After the placement of the outer sheath into the peritoneal cavity, 500-1500 ml of 5% 
glucose solution could be infused until the tumor is fully visualized and the path for the 
radiofrequency ablation electrode could be clearly developed (Figure 5d). In case of 
diabetic patients, saline could be used instead of glucose solution. 
5.3 The other issues of artificial ascites technique 
5.3.1 Learning of the knack of artificial ascites procedure 
a. The puncture directed in the dorsal space of the liver without direct puncture of the 
liver parenchyma could be selected, but it may take longer time to achieve enough 
volume of ascites above ventral side of the target liver surface.  
b. Even though the needle sheath could not slip away from the liver parenchyma at step 
4), the solution infusion could be started slowly. Sometimes, a blood back flow is seen 
after stylet removal through the needle sheath, but if the blood flow does not come from 
a hepatic artery, usually the solution infusion can be started. The back flow of the 
solution infusion from the liver parenchyma would make the ultrasonographically 
visible thin layer of the solution showing faint blinking streams around the liver (Figure 
4e, 4f). At that time, respiratory movement might affect the drip infusion while it stops 
during the time of the expiration and it starts during the time of the inspiration due to 
the change of abdominal pressure. 
c. If an outflow of the blinking stream through hepatic vein could be observed (Figure 4g), 
the physician should stop infusion and retry the puncture. 
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Fig. 5. The diagrams show the procedure to obtain artificial ascites during radiofrequency 
ablation.  
a. The insertion of the 18-gauge sheathed needle into the parenchyma of the liver. 
b. The removal of the inner stylet of the sheathed needle.  
c. The placement of the outer needle sheath in the perihepatic intraperitoneal space.  
d. The achievement of the artificial ascites that can visualize the whole tumor and the path 
for the RFA electrode. 
e. The faint blinking streams of the back flow of the solution infusion from the outer 
sheath needle in the liver parenchyma. 
f. The faint blinking streams around the liver. 
g. The unsuccessful streams of solution outflowing to the hepatic vein 
d. It is reported that oxygen saturation decreased by only 2.3% even in performing 
artificial pleural effusion (McGhana & Dodd, 2001) and most of the solution infused into 
the peritoneal cavity would disappear in 3 to 7 days in our experience.  
e. Artificial ascites technique can be used in the cases that hepatocellular carcinoma is 
located at ventral or dorsal side beneath the liver capsule in order to avoid the thermal 
effect to the abdominal wall or gastrointestinal tract (Kondo et al, 2006).  
5.3.2 Technical pitfalls of artificial ascites procedure 
The infusion should not be vigorously performed until enough thickness (about 2 to 5 mm) 
of the layer could be detected because such infusion often causes the sheath dislocation from 
the first placed site and produces an unintended inflow to the abdominal wall. The 
physicians often notice such inflow with the swelling of the puncture site or an 
ultrasonographic thickening of the abdominal wall. In this case, the physicians should also 
remove the sheath as soon as possible and retry the puncture, but it often becomes more 
difficult to insert from the same site because the abdominal wall becomes thicker than the 
distance that the puncture needle can reach. Therefore, the physicians should try to find 
another appropriate site for a puncture or try it again another day.  
5.3.3 Out of the indication of artificial ascites 
If the patients have histories of abdominal operation or peritonitis, the adhesions between 
the liver and the abdominal wall might be hazardous to have successful artificial ascites. In 
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those cases, the other locoregional treatments like transcatheter arterial chemoembolization, 
percutaneous ethanol injection therapy, or computed tomography guided radiofrequency 
ablation could be suitable procedures to treat the patients.  
6. Conclusion 
The patients who have undergone radiofrequency ablation for hepatic tumors adjacent to 
the diaphragm should be carefully followed up for possible diaphragmatic hernia, even 
after the long postoperative intervals. The artificial ascites technique can be used not only to 
visualize the whole HCC under the diaphragm, but also to reduce the unavoidable and 
unintended thermal complications of the diaphragm and the surrounding organs if 
successfully performed. 
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